OTC Drugmaker Says BioZone Breached Cold Meds Contract

Law360, New York (March 20, 2012, 1:38 PM EDT) -- An over-the-counter drug manufacturer sued BioZone Laboratories Inc. in Maryland federal court Monday, alleging the research and development company breached its contract by providing worthless cough and cold drugs that failed to meet government standards.

Aphena Pharma Solutions – Maryland LLC paid BioZone several hundred thousand dollars to develop 14 private-label over-the-counter cough and cold products — equivalent to drugs like Robitussin or Nyquil — which Aphena would manufacture, package and sell to national chain drugstores and supermarkets, according to the complaint.

Although BioZone claimed it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.